SCHEMBL19204856

SCHEMBL19204856

Fc1cccc2c(I)nn(C3CCCCO3)c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.42
CYP4F2 P78329 3/20 0.39
CYP4A11 Q02928 3/20 0.39
ALDH1A1 P00352 2/20 0.37
HPGD P15428 1/20 0.36
LMNA P02545 2/20 0.36
MAPT P10636 1/20 0.36
ATR Q13535 3/20 0.34
POLB P06746 1/20 0.34
GAA P10253 1/20 0.33
MAP3K5 Q99683 1/20 0.33
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB1 P18505 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRA2 P47869 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19204851 0.85 ESR1 (0.42) ESR1CYP4F2CYP4A11ALDH1A1HPGD
SCHEMBL19249525 0.85 ESR1 (0.42) ESR1CYP4F2CYP4A11ALDH1A1HPGD
SCHEMBL24122149 0.85 ALDH1A1 (0.36) CYP4F2CYP4A11ALDH1A1LMNAPOLB
SCHEMBL28348643 0.85 ESR1 (0.42) ESR1CYP4F2CYP4A11ALDH1A1HPGD
SCHEMBL30242675 0.82 CYP4F2 (0.47) ESR1CYP4F2CYP4A11ALDH1A1LMNA
SCHEMBL24012790 0.82 CYP4F2 (0.47) ESR1CYP4F2CYP4A11ALDH1A1LMNA
SCHEMBL19255770 0.82 CYP4F2 (0.41) ESR1CYP4F2CYP4A11ALDH1A1LMNA
SCHEMBL31411379 0.81 ESR1 (0.40) ESR1CYP4F2CYP4A11ALDH1A1HPGD
SCHEMBL19250639 0.81 CYP4F2 (0.38) ESR1CYP4F2CYP4A11ALDH1A1LMNA
SCHEMBL19204837 0.80 CYP4F2 (0.38) ESR1CYP4F2CYP4A11ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017133670-A1 PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA SAVIRA PHARMACEUTICALS GMBH (AT) 2017-08-10 WO disclosed
WO-2017133664-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA SAVIRA PHARMACEUTICALS GMBH (AT) 2017-08-10 WO disclosed
WO-2017133667-A1 PYRIMIDINE AND PYRIDINE DERIVATIVES AND USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA THEREOF SAVIRA PHARMACEUTICALS GMBH (AT) 2017-08-10 WO disclosed